Invivo’s DynaCAD with ONCAD offers a new way of interpreting magnetic resonance imaging (MRI). ONCAD is the first, fully automated morphological analysis system designed to detect suspicious breast lesions as part of a second check during review of contrast enhanced MRI.
ONCAD delivers clinically tested morphological analysis based on patented algorithms. It automatically analyzes the entire breast and draws attention to abnormal morphology with a color overlay.
For more information: www.invivocorp.com
June 30, 2026 
